Dysregulation of AKT/mTOR signaling is frequently observed in the context of HCC, and the integrin-mediated interaction between POSTN and AKT/mTOR pathway becomes a key regulatory axis for HCC progression. This evidence concerns the gene MTOR and hepatocellular carcinoma.